These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 155971)

  • 21. Enhancement by caffeine of neocarzinostatin cytotoxicity in murine leukemia L1210 cells.
    Tatsumi K; Tashima M; Shirakawa S; Nakamura T; Uchino H
    Cancer Res; 1979 May; 39(5):1623-7. PubMed ID: 154973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemotherapy and immuno-chemotherapy in malignant lymphoma].
    Nishikori M; Nasu K; Shirakawa S; Karitani Y
    Rinsho Ketsueki; 1983 Apr; 24(4):320-9. PubMed ID: 6350639
    [No Abstract]   [Full Text] [Related]  

  • 23. [Histological effect of SMANCS/LPD therapy in renal cell carcinoma].
    Suzuki T; Kobayashi M; Nakamura T; Takahashi O; Imai K; Yamanaka H; Suzuki K; Konno T; Maeda H
    Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2210-7. PubMed ID: 2833546
    [No Abstract]   [Full Text] [Related]  

  • 24. [The clinical evaluation of a new antileukemic agent. 2) Neocarzinostatin (author's transl)].
    Kitajima K
    Nihon Ketsueki Gakkai Zasshi; 1974 Oct; 37(5):767-72. PubMed ID: 4282818
    [No Abstract]   [Full Text] [Related]  

  • 25. [Rubidomycin in the treatment of acute leukemia (32 cases)].
    Goudemand M; Sautière-Habay D; Delmas-Marsalet Y
    Lille Med; 1967 Nov; 12(9):1163-70. PubMed ID: 5272306
    [No Abstract]   [Full Text] [Related]  

  • 26. [ACNP therapy for DCMP-resistant acute leukemia (author's transl)].
    Naoe T; Hiraiwa A; Akao Y; Tahara T; Yoshikawa H; Yoshikawa S; Naito K; Yamaguchi H
    Rinsho Ketsueki; 1981 Oct; 22(10):1538-44. PubMed ID: 6460886
    [No Abstract]   [Full Text] [Related]  

  • 27. Monoclonal antibody therapy of lymphoid malignancy.
    Lowder JN; Meeker TC; Levy R
    Cancer Surv; 1985; 4(2):359-75. PubMed ID: 3842318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I study of neocarzinostatin in patients with acute leukemia.
    Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1978 Sep; 62(9):1363-5. PubMed ID: 150945
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunological approach to the treatment of acute lymphoblastic leukemia.
    Bergolz VM; Kisljak NS; Eremeev VS; Rumjantzev AG; Akimova GV; Osipov SG
    Neoplasma; 1980; 27(4):355-61. PubMed ID: 6935532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotics and chemotherapy of malignant neoplasms.
    Shorin VA
    Antibiotiki; 1967 Nov; 12(11):1043-5. PubMed ID: 4173829
    [No Abstract]   [Full Text] [Related]  

  • 31. [Nucleoside analogues--new drugs for the treatment of lymphatic cancers].
    Itälä M; Remes K
    Duodecim; 2001; 117(2):162-9. PubMed ID: 12092367
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of carminomycin on adult patients with acute leukemias].
    Faĭnshteĭn FE; Kovaleva LG; Vakhrusheva MV; Isaev VG; Abakumov EM
    Antibiotiki; 1977 Aug; 22(8):756-8. PubMed ID: 334058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I study of neocarzinostatin in children with cancer.
    Rivera G; Howarth C; Aur RJ; Pratt CB
    Cancer Treat Rep; 1978 Dec; 62(12):2105-7. PubMed ID: 156067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies of cell content and surface and secretory immunoglobulins in myeloma, macroglobulinemia, malignant lymphoma and related leukemic diseases].
    Miyoshi K; Kosaka M; Tamora R; Numata Y; Takamato M
    Nihon Rinsho; 1976 May; 34(5):945-53. PubMed ID: 824476
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunoglobulin substitution in malignant lymphoma].
    Wehmeier A
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():73-6; discussion 77. PubMed ID: 8499755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetic one-compartment model using neocarzinostain as a prototype drug and its clinical application to chemotherapy for brain tumor. Part II. A clinical trial with selected protocol].
    Matsukado Y; Maeda H; Uemura S; Kuratsu J; Sonoda H
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1933-41. PubMed ID: 6223589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia.
    Jones B; Holland JF; Morrison AR; Lee SL; Sinks LF; Cuttner J; Rausen A; Kung F; Pluss HJ; Haurani FI; Patterson RB; Blom J; Burgert EO; Moon JH; Chevalier L; Sawitsky A; Albala MM; Forcier RJ; Falkson G; Glidewell O
    Cancer Res; 1971 Feb; 31(2):84-90. PubMed ID: 5278102
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of intraperitoneal therapy in gastric cancer with peritoneal dissemination].
    Kajiura Y; Ogoshi K; Nakamura K; Miyaji M; Kondoh Y; Makuuchi H; Tajima T; Mitomi T
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1863-6. PubMed ID: 9382552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of meningeal carcinomatosis--neocarzinostatin perfusion therapy in the CSF pathway].
    Uemura S; Matsukado Y; Fujioka S; Kuratsu J; Sonoda H; Yano T; Ohtsuka T; Yoshioka S
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1794-800. PubMed ID: 2931051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antineoplastic activity of a new antibiotic agent carminomycin].
    Shorin VA; Bazhanov VS; Averbuch LA; Lepeshkina GN; Grinshteĭn AM
    Antibiotiki; 1973 Aug; 18(8):681-6. PubMed ID: 4521406
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.